Pfizer SARS-CoV-2 protease inhibitor PF-07321332 and SARS-CoV-2 protease, molecular models. The image shows the protease (top) and the inhibitor (bottom). As of 2021, the clinical candidate PF-07321332 is a potent protease inhibitor with potent anti-viral activity against SARS-CoV-2.

px px dpi = cm x cm = MB
Details

Creative#:

TOP27148702

Source:

達志影像

Authorization Type:

RM

Release Information:

須由TPG 完整授權

Model Release:

N/A

Property Release:

N/A

Right to Privacy:

No

Same folder images:

Same folder images